The database will be searchable by demographics, dosage, intervention and outcome, explains Ellen Schutt, executive director, GOED.

Sandy Almendarez, VP of Content

November 27, 2019

1 Min Read
Omega Magnifying glass_406683670_1.jpg

The Omega-3 Clinical Study Database, now in phase 2 data extraction, will one day be a searchable database of human clinical trials that examined the effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), or the combination of those two long-chain omega-3s.

GOED (The Global Organization for EPA and DHA Omega-3s) started this endeavor two years ago, as Ellen Schutt, executive director, explains in this Healthy Insider Podcast, and has narrowed down 35,000 potential studies into 4,000 specifically focused on EPA/DHA that need to be categorized for demographics, dosage, intervention and outcome.

With Sandy Almendarez, content director, INSIDER, Schutt talks about the Omega-3 Clinical Study Database, including:

  • Who will benefit from the database and who will have access

  • How this database will be different from other research archives, such as PubMed.

  • How attendees of the 2020 GOED Exchange will see sneak peek of the database.

Learn more about the Omega-3 Clinical Study Database from Aldo Bernasconi, Ph.D., director of information and research, GOED, at the GOED Exchange, Feb. 4 to 6, 2020 in Barcelona, Spain.

About the Author(s)

Sandy Almendarez

Sandy Almendarez

VP of Content, Informa

Summary

• Well-known subject matter expert within the health & nutrition industry with more than 15 years’ experience reporting on natural products.

• She cares a lot about how healthy products are made, where their ingredients are sourced and how they affect human health.

• She knows that it’s the people behind the businesses — their motivations, feelings and emotions — drive industry growth, so that’s where she looks for content opportunities.

Sandy Almendarez is VP of Content for SupplySide and an award-winning journalist. She oversees the editorial and content marketing teams for the B2B media brands Natural Products Insider and Food and Beverage Insider, the education programming for the health and nutrition trade shows SupplySide East and SupplySide West, and community engagement across the SupplySide portfolio. She is a seasoned content strategist with a passion for health, good nutrition, sustainability and inclusion. With over 15 years of experience in the health and nutrition industry, Sandy brings a wealth of knowledge to her role as a content-focused business leader. With specialization in topics ranging from product development to content engagement, creative marketing and c-suite decision making, her work is known for its engaging style and its relevance for business leaders in the health and nutrition industry.

In her free time, Sandy loves running, drinking hot tea and watching her two kids grow up. She brews her own “Sandbucha” homemade kombucha; she’s happy to share if you’re ever in Phoenix!

Awards:

Speaker credentials

Resides in

  • Phoenix, AZ

Education

  • Arizona State University

Contact:

See more from Sandy Almendarez
Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like

Recommended

Supplement Regulations
NY law targeting dietary supplements mired in CRN, NPA litigation
NY law targeting dietary supplements mired in CRN, NPA litigation

Mar 13, 2024

Supplement Regulations
FDA seeks dietary supplement listing requirement in FY25 budget proposal
FDA seeks dietary supplement listing requirement in FY25 budget proposal

Mar 12, 2024

Supplement Regulations
FDA NDI guidance: Five key takeaways
FDA NDI guidance for supplement companies: Five key takeaways

Mar 12, 2024

Market Trends & Analysis
Amway’s revenues continue decade-long slide, dropping to $7.7 billion
Amway's annual revenues drop by 5%

Mar 12, 2024

Recent headlines